DeSci leaders are also getting creative. Can Pump.science do well with "biological science memes"?

Author: Zhouzhou, BlockBeats

At the Solana Breakpoint conference during Token 2049, the Solana ecosystem Desci platform Molecule DAO launched a new meme token issuance platform, Pump.Science. Unlike other meme token platforms, Pump.Science's feature lies not in the token issuance mechanism; medical researchers can submit drug research proposals on Pump.Science, then test the drugs on worms and transmit the experimental results to the platform's frontend. In this process, users can participate in the experimental process by trading meme tokens that represent the drugs.

Introducing meme tokens to "incentivize" drug research

Pump.Science can be understood as a token-based longevity experiment prediction game. Pump.Science will issue meme tokens representing drugs on Pump.fun, allowing players to trade directly. When the market capitalization reaches $10,000, the medical research organization ORA Biomedical will use the drug in experiments and regularly publish the results on the PUMP.SCIENCE platform. Based on this, players can predict the drug's effects and continue trading meme tokens according to the experimental results.

After entering the official Pump.Science website, users can choose to support proposals submitted by others and purchase related tokens. When the market capitalization of a certain token reaches the startup amount, the drug will be used in experiments. During this process, users can view experimental data in real-time and assess the drug's effectiveness.

Pump.Science introduces a drug experiment prediction mechanism, where purchasing meme tokens is equivalent to voting for a certain drug. Ideally, if the token price trend synchronizes with the drug trial data performance, it can provide incentive schemes for medical research, gamifying longevity research. Users can determine whether the drug strategy can extend human lifespan based on experimental data, thus participating in investment decisions.

Upon entering the Pump.Science interface, users can see the Marketplace page, which displays the experimental effects and price curves of completed projects, facilitating user comparisons. Clicking on one of the experimental projects, Rifampicin, the system shows the experimental results and market data for this compound. Compared to the control group of worms, Rifampicin shows a 32.87% lifespan extension effect, with a higher "Percentage Lifespan Extension" (PLE) indicating greater potential returns, encouraging users to participate actively.

According to Molecule DAO, longevity research is facing challenges similar to those in the crypto field, including costs, data reading times, and data quality issues. In response, Molecule DAO has introduced a medical experiment mechanism using "worms" with a lifespan of 20 days as experimental subjects, allowing ordinary users to participate in medical research through meme token trading, while researchers can obtain experimental results more quickly and at a lower cost.

The Wormbo platform, developed by Ora Biomedical, founded by Matt Kaeberlein and Mitchell Lee, is a low-cost, rapid experimental platform specifically designed to test a large number of potential longevity therapies at a lower cost, using 20-day lifespan worms as experimental subjects, making it very suitable for rapid screening and analysis in life health experiments.

How long will the "Web3 + Research" market remain cold?

The launch of Pump.Science by Molecule DAO, a biotechnology research fundraising platform founded by Tyler Golato and Paul Kohlhaas, follows its investment in the open-source drug development organization LabDAO and a $100 investment from Sora Ventures.

Molecule DAO proposes to utilize IP-NFT technology to combine intellectual property with cryptocurrency, allowing for the shared ownership of research projects. The founders of Molecule DAO, Golato and Kohlhaas, also created Bio.xyz, focusing on helping DeSci DAOs utilize IP-NFTs to fund, manage, and develop global university intellectual property DeSci accelerators.

Currently, Pump.Science has only launched two tokens, Urokinase ($URO) and Rifampicin ($RIF), allowing users to participate in predicting and trading experimental results. The $RIF and $URO tokens went live on the evening of September 21, and within two hours of their launch, both tokens surged 20 times in value but then quickly dropped over 90%, with only 29 transactions in the last 24 hours.

The launch of Pump.Science represents another exploration by Molecule DAO on its path, expanding the commercialization and funding channels for scientific research results. However, for current traders, a preference for projects with stronger liquidity means that recognition is the key driving force behind meme tokens, rather than scientific value. As a result, the market response to Pump.Science has been below expectations. With the project's further development, more tokens may be launched in the future, providing users with more choices and participation opportunities, and the subsequent development of Desci remains worth watching.